Reimportation And Senate Donations

3 Comments

money.jpg

Lobbying is an inherent aspect of the messy Democratic party. And that’s fine. No reason, though, not to keep tabs on who’s giving and who’s getting. And that’s what USA Today does in a piece that, with the help of the Center for Responsive Politics and PoliticalMoneyLine, looks at contributions received by senators who voted this week to defeat reimportation.

Here’s the skinny: the senators who raised millions of dollars in campaign donations from pharmaceutical interests secured industry-friendly changes to a landmark drug-safety bill, which passed 93-1.

The effort reflected concerns that the FDA would begin paring staff this summer if the debate went on too long without a bill that could be reconciledd with drug-safety legislation already passed by the House, The New York Times reports.

However, the powers granted to the FDA in the bill’s original version were pared back during private meetings. And efforts to curb conflicts of interest among FDA advisers and allow consumers to buy cheaper drugs from other countries were defeated in close votes.

A measure that blocked an effort to allow drug importation passed, 49-40. The 49 senators who voted against drug importation received about $5 million from industry executives and political action committees since 2001 — nearly three quarters of the industry donations to current members of the Senate.

Here are the top recipients of contributions from pharmaceutical executives and political action committees from 2001 through March, and how they voted. A ‘yes’ supported drugmakers. Topping the list was North Carolina’s Richard Burr (that’s him to the right).

richardburr.jpg

Richard Burr, R-N.C. $520,694 Yes

John Kerry, D-Mass. $304,888 Yes

Joe Lieberman, I-Conn. $281,040 Yes

Arlen Specter, R-Pa. $259,699 Yes

Orrin Hatch, R-Utah $241,850 Yes

Chuck Grassley, R-Iowa $216,599 No

Max Baucus, D-Mont. $199,000 Yes

Chris Dodd, D-Conn. $192,025 Did not vote

Tom Carper, D-Del. $183,794 Yes

Mike Enzi, R-Wyo. $174,338 Yes

Further reading…
The USA Today story;
Center for Responsive Politics;
PoliticalMoneyLine.
The New York Times (registration required).

[tags]Contributions, Lobbying, Political Influence, Reimportation[/tags]

Jump to comments

Share

Comments

  1. Knowing who the players are–who serves Big Pharma and who serves the people–will hopefully impact the next election cycle. Big Pharma can BUY legislators; they can certainly influence voters . . . but I think citizens are becoming disenchanted with Big Pharma and the hidden message (profits before patients) that is different from their PR flak.

    Let’s hope this disenchantment (with both BigPharma and their legislative shills) extends to the next election, and citizens show even more legislators that we want representation–not hollow slogans and unkept promises.

  2. Of course, this is a “chicken or egg” situation. Do these Senators vote a certain way because they receive support from Big Pharma or do they receive support because they already have opinions that coincide with Big Pharma? The latter is probably more accurate. Of course, there are certainly key Senators who receive support but don’t necessarily see eye to eye with Big Pharma–eg, Grassley and Clinton. In those cases, contribution tend to allow access to at least discuss issues.

  3. What about Obama not voting? Was that almost as bad as voting against reimportation?
    I think that Dodd, Obama and Biden did great harm by not voting and showed their support for Pharma.

Subscribe

RSS Feed

Comments feed for this post only.

Tags

, , ,

Clear

Clear

All rights reserved, Nojasa LLC. Copyright, Nojasa LLC.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/